N -(1 H -Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies-Reference-Cited by-同舟云学术

N -(1 H -Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies

Published:2017-06 Issue:12 Volume:27 Page:2663-2667
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Karthikeyan Chandrabose,Jharia Pramod,Waiker Digambar Kumar,Nusbaum Amy Catherine,Amawi Haneen,Kirwen Erin Marie,Christman Ryann,Arudra Sri Krishna Chaitanya,Meijer Laurent,Tiwari Amit K.,Trivedi Piyush

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. Pharmacological inhibitors of glycogen synthase kinase 3;Meijer;Trends Pharmacol Sci,2004

2. Tackling the phosphoproteome: tools and strategies;Kalume;Curr Opin Chem Biol,2003

3. The protein kinase complement of the human genome;Manning;Science (New York, NY),2002

4. Protein tyrosine phosphatases in the human genome;Alonso;Cell,2004

5. Regulation and function of protein kinases and phosphatases;Cheng;Enzyme Res,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach;Bioorganic Chemistry;2024-06

2. Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta;Pharmaceuticals;2024-04-07

3. Computer-Assisted Drug Design: A Toolbox for Novel Tau Kinase Inhibitors and Its Implications in Alzheimer’s Disease;Neuromethods;2023

4. Substituent Orchestration in Dimethylquinoxaline Derivatives: A Tool for Fishing Out Appropriate CDK5 Inhibitors as Potential Therapeutics for Alzheimer's;Chemistry & Biodiversity;2022-08-19

5. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders;Current Medicinal Chemistry;2022-08